The EU General Court has dismissed a request to revoke a syringe trademark on the grounds of non-use, partially affirming the initial decision of the Cancellation Division.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
EU General Court, European Union Intellectual Property Office, Covidien, Hansen Medical, Magellan, medical trademark, trademark revocation
